This compound is a known inducer of phase II detox enzymes in large part due to its activation of Nrf2, a transcription factor regulating key antioxidant and phase II detoxifying enzymes including NQO1 and glutathione-S-transferase (GST)
Instead, it works primarily by modulating inflammation, promoting blood vessel formation, and supporting the healing of surrounding soft tissues
While GLP-1 medication can support your weight goals, it is not a quick fix or a standalone solution
Three years later, in 2024, the FDA also approved it to reduce the risk of cardiovascular death, heart attack, and stroke for people who have obesity or overweight as well as cardiovascular disease
In IEEE 19th International Conference on e-Science (e-Science) , 110 (2023)
Building your personalized GHK-CU protocol Theory becomes useful only through application